Literature DB >> 15564470

Molecular characterization of human immunodeficiency virus type 1 and hepatitis C virus in paid blood donors and injection drug users in china.

Linqi Zhang1, Zhiwei Chen, Yunzhen Cao, Jian Yu, Guanghan Li, Wenjie Yu, Ning Yin, Shan Mei, Li Li, Peter Balfe, Tian He, Lei Ba, Fengwen Zhang, His-Hsun Lin, Man-Fung Yuen, Ching-Lung Lai, David D Ho.   

Abstract

China is facing a rapid upsurge in cases of human immunodeficiency virus type 1 (HIV-1) and hepatitis C virus (HCV) infection due to large numbers of paid blood donors (PBD), injection drug users (IDU), and sexual partners of infected individuals. In this report, a total of 236 HIV-1-positive blood samples were collected from PBD, IDU, and their sexual partners in the most severely affected provinces, such as Henan, Yunnan, Guangxi, and Xinjiang. PCR was used to amplify the p17 region of gag and the C2-V3 region of env of HIV-1 and the 5' noncoding region and a region of E1/E2 of HCV. Genetic characterization of viral sequences indicated that there are two major epidemics of HIV-1 and multiple HCV epidemics in China. The PBD and transfusion recipients in Henan harbored HIV-1 subtype B', which is similar to the virus found in Thailand, and HCV genotypes 1b and 2a, whereas the IDU in Yunnan, Guangxi, and Xinjiang carried HIV-1 circulating recombinant forms 07 and 08, which resemble those in India, and HCV genotypes 1b, 3a, and 3b. Our findings show that the epidemics of HIV-1 and HCV infection in China are the consequences of multiple introductions. The distinct distribution patterns of both the HIV-1 and HCV genotypes in the different high-risk groups are tightly linked to the mode of transmission rather than geographic proximity. These findings provide information relevant to antiviral therapy and vaccine development in China and should assist public health workers in implementing measures to reduce the further dissemination of these viruses in the world's most populous nation.

Entities:  

Mesh:

Year:  2004        PMID: 15564470      PMCID: PMC533913          DOI: 10.1128/JVI.78.24.13591-13599.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  41 in total

1.  "Blood heads" and AIDS haunt China's countryside.

Authors:  M V Beach
Journal:  Lancet       Date:  2001-01-06       Impact factor: 79.321

Review 2.  Understanding the genetic diversity of HIV-1.

Authors:  F E McCutchan
Journal:  AIDS       Date:  2000       Impact factor: 4.177

3.  [The survey of prevalence of HIV infection among paid blood donors in one county in China].

Authors:  J Yan; X Zheng; X Zhang; S Liu; Y Zhang; C Wang; S Liu
Journal:  Zhonghua Liu Xing Bing Xue Za Zhi       Date:  2000-02

Review 4.  The origin and evolution of hepatitis viruses in humans.

Authors:  Peter Simmonds
Journal:  J Gen Virol       Date:  2001-04       Impact factor: 3.891

5.  Emerging HIV infections with distinct subtypes of HIV-1 infection among injection drug users from geographically separate locations in Guangxi Province, China.

Authors:  X F Yu; J Chen; Y Shao; C Beyrer; B Liu; Z Wang; W Liu; J Yang; S Liang; R P Viscidi; J Gu; G Gurri-Glass; S Lai
Journal:  J Acquir Immune Defic Syndr       Date:  1999-10-01       Impact factor: 3.731

6.  [The natural history of HIV infection among IDUs in Ruili, Yunnan province, China].

Authors:  X Zheng; J Zhang; X Wang; S Duan; S Qu; Y Duan; G Zhang
Journal:  Zhonghua Liu Xing Bing Xue Za Zhi       Date:  2000-02

7.  [Residual risk research of HIV infection after blood screening in one county in China].

Authors:  X Zheng; Z Mei; C Wang; L Wang; P Guo; X Qiao; A Liu; Y Mao
Journal:  Zhonghua Liu Xing Bing Xue Za Zhi       Date:  2000-02

8.  Characterization of a virtually full-length human immunodeficiency virus type 1 genome of a prevalent intersubtype (C/B') recombinant strain in China.

Authors:  L Su; M Graf; Y Zhang; H von Briesen; H Xing; J Köstler; H Melzl; H Wolf; Y Shao; R Wagner
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

9.  A recent outbreak of human immunodeficiency virus type 1 infection in southern China was initiated by two highly homogeneous, geographically separated strains, circulating recombinant form AE and a novel BC recombinant.

Authors:  S Piyasirisilp; F E McCutchan; J K Carr; E Sanders-Buell; W Liu; J Chen; R Wagner; H Wolf; Y Shao; S Lai; C Beyrer; X F Yu
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

10.  [A cohort study of HIV infection among intravenous drug users in Ruili and other two counties in Yunnan Province, China, 1992-1995].

Authors:  X Zheng; J P Zhang; S Q Qu
Journal:  Zhonghua Liu Xing Bing Xue Za Zhi       Date:  1997-10
View more
  46 in total

1.  Serological assay and genotyping of hepatitis C virus in infected patients in zanjan province.

Authors:  Abdolreza Esmaeilzadeh; Maryam Erfanmanesh; Sousan Ghasemi; Farzaneh Mohammadi
Journal:  Hepat Mon       Date:  2014-09-27       Impact factor: 0.660

2.  Genetic and neutralization sensitivity of diverse HIV-1 env clones from chronically infected patients in China.

Authors:  Hong Shang; Xiaoxu Han; Xuanling Shi; Teng Zuo; Mark Goldin; Dan Chen; Bing Han; Wei Sun; Hao Wu; Xinquan Wang; Linqi Zhang
Journal:  J Biol Chem       Date:  2011-02-16       Impact factor: 5.157

3.  Comparative evaluation of the ViroSeq™ HIV-1 genotyping system and an in-house method for analysis of HIV-1 drug-resistance mutations in China.

Authors:  Sihong Xu; Ping Zhong; Jingyun Li; Aijing Song; Hanping Li; Jianhui Nie; Xiuhua Li; Youchun Wang
Journal:  Mol Diagn Ther       Date:  2011-02-01       Impact factor: 4.074

4.  Prevalence of drug-resistant HIV-1 in rural areas of Hubei province in the People's Republic of China.

Authors:  Minqi Luo; Huan Liu; Ke Zhuang; Li Liu; Bo Su; Rongrong Yang; Po Tien; Linqi Zhang; Xien Gui; Zhiwei Chen
Journal:  J Acquir Immune Defic Syndr       Date:  2009-01-01       Impact factor: 3.731

5.  High prevalence and genetic diversity of HCV among HIV-1 infected people from various high-risk groups in China.

Authors:  Hong Shang; Ping Zhong; Jing Liu; Xiaoxu Han; Di Dai; Min Zhang; Ke Zhao; Rongzhen Xu; Xiao-Fang Yu
Journal:  PLoS One       Date:  2010-05-27       Impact factor: 3.240

6.  Phase 1 safety and immunogenicity evaluation of ADMVA, a multigenic, modified vaccinia Ankara-HIV-1 B'/C candidate vaccine.

Authors:  Sandhya Vasan; Sarah J Schlesinger; Zhiwei Chen; Arlene Hurley; Angela Lombardo; Soe Than; Phumla Adesanya; Catherine Bunce; Mark Boaz; Rosanne Boyle; Eddy Sayeed; Lorna Clark; Daniel Dugin; Mar Boente-Carrera; Claudia Schmidt; Qing Fang; Yaoxing Huang; Gerasimos J Zaharatos; David F Gardiner; Marina Caskey; Laura Seamons; Martin Ho; Len Dally; Carol Smith; Josephine Cox; Dilbinder Gill; Jill Gilmour; Michael C Keefer; Patricia Fast; David D Ho
Journal:  PLoS One       Date:  2010-01-25       Impact factor: 3.240

7.  Phase 1 safety and immunogenicity evaluation of ADVAX, a multigenic, DNA-based clade C/B' HIV-1 candidate vaccine.

Authors:  Sandhya Vasan; Sarah J Schlesinger; Yaoxing Huang; Arlene Hurley; Angela Lombardo; Zhiwei Chen; Soe Than; Phumla Adesanya; Catherine Bunce; Mark Boaz; Rosanne Boyle; Eddy Sayeed; Lorna Clark; Daniel Dugin; Claudia Schmidt; Yang Song; Laura Seamons; Len Dally; Martin Ho; Carol Smith; Martin Markowitz; Josephine Cox; Dilbinder K Gill; Jill Gilmour; Michael C Keefer; Patricia Fast; David D Ho
Journal:  PLoS One       Date:  2010-01-25       Impact factor: 3.240

8.  HIV-infected former plasma donors in rural Central China: from infection to survival outcomes, 1985-2008.

Authors:  Zhihui Dou; Ray Y Chen; Zhe Wang; Guoping Ji; Guoping Peng; Xiaochun Qiao; Jihua Fu; Xiangdong Meng; Marc Bulterys; Ye Ma; Yan Zhao; Ning Wang; Fujie Zhang
Journal:  PLoS One       Date:  2010-10-29       Impact factor: 3.240

9.  HCV coinfection associated with slower disease progression in HIV-infected former plasma donors naïve to ART.

Authors:  Xiaoyan Zhang; Jianqing Xu; Hong Peng; Yan Ma; Lifeng Han; Yuhua Ruan; Bing Su; Ning Wang; Yiming Shao
Journal:  PLoS One       Date:  2008-12-22       Impact factor: 3.240

10.  Human immunodeficiency virus type 1 subtypes prevalence in central China.

Authors:  Fei Zhao; Zhe Wang; Wen-Jie Li
Journal:  Yonsei Med J       Date:  2009-10-21       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.